Kymera Therapeutics share price today
(NASDAQ: KYMR)
Kymera Therapeutics share price is $44.23 & ₹3,825.45 as on 24 Jan 2025, 2.30 'hrs' IST
$44.23
▲
0.1
(0.23%)
Market is closed - opens 8 PM, 24 Jan 2025
View live Kymera Therapeutics share price in Dollar and Rupees. Guide to invest in Kymera Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Kymera Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.
Kymera Therapeutics share price movements
- Today's Low: $42.99Today's High: $44.80
2.81%
Downside
Day's Volatility :4.05%
Upside
1.27%
- 52 Weeks Low: $29.2452 Weeks High: $53.27
33.89%
Downside
52 Weeks Volatility :45.11%
Upside
16.97%
Kymera Therapeutics Returns
Kymera Therapeutics Key Statistics
in dollars & INR
How to invest in Kymera Therapeutics Stock (KYMR) from India?
It is very easy for Indian residents to invest directly in Kymera Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Kymera Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Kymera Therapeutics or KYMR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Kymera Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.
For example: You can easily buy Rs.100 worth of Kymera Therapeutics shares which would translate to 0.020 fractional shares of Kymera Therapeutics as of today. Learn more about fractional investing.
Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Kymera Therapeutics, in just a few clicks!
Returns in Kymera Therapeutics for Indian investors in Rupees
Investment Value
₹1,00,000
Kymera Therapeutics investment value today
Current value as on today
₹1,42,968
Returns
₹42,968
(+42.97%)
Returns from Kymera Therapeutics Stock
₹38,913 (+38.91%)
Dollar Returns
₹4,054 (+4.05%)
Indian investors sentiment towards Kymera Therapeutics
Global Institutional Holdings in Kymera Therapeutics
T. Rowe Price Associates, Inc.
10.26%
Baker Bros Advisors LP
9.26%
Bvf Inc
7.97%
FMR Inc
7.89%
Vanguard Group Inc
7.34%
Wellington Management Company LLP
7.13%
Analyst Recommendation on Kymera Therapeutics
Buy
69%Buy
30%Hold
0%Sell
Based on 23 Wall street analysts offering stock ratings for Kymera Therapeutics(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Analyst Forecast on Kymera Therapeutics
What analysts predicted
Upside of 33.04%
Target:
$58.84
Current:
$44.23
Insights on Kymera Therapeutics
Price Movement
In the last 7 days, KYMR stock has moved up by 9.5%Decreasing Revenue
Revenue is down for the last 2 quarters, 25.65M → 3.74M (in $), with an average decrease of 85.4% per quarterDecreasing Net Profit
Netprofit is down for the last 2 quarters, -42.06M → -62.48M (in $), with an average decrease of 48.6% per quarterKYMR vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 95.4% return, outperforming this stock by 79.4%
Kymera Therapeutics Technicals Summary
Sell
Neutral
Buy
Kymera Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Kymera Therapeutics Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 5.02% | -0.92% | 38.6% | 10.99% | 32.68% |
 | 0.91% | 34.01% | 18.85% | -26.4% | 246.9% |
 | -4.82% | -36.95% | -28.33% | 12.74% | 100.35% |
 | 4.86% | -13.58% | -0.46% | 88.45% | 88.24% |
 | 9.57% | 13.5% | 44.91% | 103.56% | 127.75% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -2.84 | -0.26 | -0.15 | NA | 13.79 |
| 160.8 | NA | 0.04 | -3.33 | -0.02 | -0.01 | NA | 79.73 |
| 17.02 | 17.02 | 1.05 | 44.99 | 0.17 | 0.07 | NA | 272.04 |
| 32.84 | NA | 1.1 | 0.48 | -0.03 | 0.12 | NA | 60.65 |
| NA | NA | -0.49 | -0.18 | -15.01 | -0.03 | NA | 0.25 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $2.8B | 32.68% | NA | -191.26% |
| Buy | $28.1B | 246.9% | 160.8 | -15.36% |
| Buy | $75.6B | 100.35% | 17.02 | 33.61% |
| Buy | $110.2B | 88.24% | 32.84 | -4.51% |
| Buy | $34.2B | 127.75% | NA | -15.86% |
Kymera Therapeutics Dividend announcements
Kymera Therapeutics Earnings
Kymera Therapeutics’s price-to-earnings ratio stands at None
Read More
About Kymera Therapeutics
Management People of Kymera Therapeutics
Important FAQs about investing in Kymera Therapeutics (KYMR) from India :
What is Kymera Therapeutics share price today?
Kymera Therapeutics share price today stands at $44.23, Open: $43.45 ; Previous Close: $44.13 ; High: $44.80 ; Low: $42.99 ; 52 Week High: $53.27 ; 52 Week Low: $29.24. The stock opens at $43.45, after a previous close of $44.13. The stock reached a daily high of $44.80 and a low of $42.99, with a 52-week high of $53.27 and a 52-week low of $29.24.
Can Indians buy Kymera Therapeutics shares?
Yes, Indians can invest in the Kymera Therapeutics (KYMR) from India.
With INDmoney, you can buy Kymera Therapeutics at 0 brokerage. The step-by-step process is as follows:
- Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
- Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
- Once funds are transferred successfully, you can buy Kymera Therapeutics at zero transaction cost.
How can I buy Kymera Therapeutics shares from India?
It is very easy to buy Kymera Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.
Can Fractional shares of Kymera Therapeutics be purchased?
Yes, you can buy fractional shares of Kymera Therapeutics with INDmoney app.
What are the documents required to start investing in Kymera Therapeutics stocks?
To start investing in Kymera Therapeutics, You will need the following documents:
- Proof of Identification (PAN, Aadhaar etc)
- Proof of address (Aadhaar, Voter ID etc)
These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.
What are today’s High and Low prices of Kymera Therapeutics
Today’s highest price of Kymera Therapeutics (KYMR) is $44.80.
Today’s lowest price of Kymera Therapeutics (KYMR) is $42.99.
What is today's market capitalisation of Kymera Therapeutics
What is the 52 Week High and Low Range of Kymera Therapeutics
52 Week High
$53.27
52 Week Low
$29.24
What are the historical returns of Kymera Therapeutics?
1 Month Returns
5.02%
3 Months Returns
-0.92%
1 Year Returns
38.6%
5 Years Returns
32.68%
Who is the Chief Executive Officer (CEO) of Kymera Therapeutics
Discover More
N-able Inc.$9.63
+0.94%
Liberty Global Plc - Class C Shares$12.14
+1.76%
Element Solutions Inc$26.19
+0.19%
Allegro Microsystems, Inc.$24.94
-0.32%
Sensient Technologies Corp$76.30
+0.81%
Payoneer Global Inc.$10.19
-0.88%
Wendy's Company, The$14.22
+0.35%
Fidelity High Dividend Etf$51.47
+0.63%
Hafnia Ltd$5.28
+4.97%